Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · Real-Time Price · USD

0.5203

-0.0110 (-2.07%)

At close: Jul 24, 2026, 4:00 PM EDT

0.5151

-0.0052 (-1.00%)

After-hours: Jul 24, 2026, 4:10 PM EDT

Citius Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Income	-58.44	-38.53	-42	-36.73	-33.32	-23.53
Net Income	-46.2	-37.43	-40.19	-33.69	-33.64	-24.51
Earnings Per Share	-2.24	-3.38	-5.97	-5.57	-5.75	-5.75
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Investments	0	0	0	26.48	41.71	70.07
Total Debt	0.81	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	-0.81	-1.81	-0.26	26	41.03	69.22
Net Cash Growth	-	-	-	-36.64%	-40.72%	453.40%
Net Cash Per Share	-0.04	-0.16	-0.04	4.30	7.02	15.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Cash Flow	-31.6	-26.55	-28.2	-29.06	-28.36	-24.25
Capital Expenditures	-	-	-	-	-	-0.01
Free Cash Flow	-31.6	-26.55	-28.2	-29.06	-28.36	-24.26
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Forward PE	-	1.37	8.71	7.11	7.11	7.88